We investigated the clinical outcomes of ST elevation myocardial infarction (STEMI) patients with refractory cardiogenic shock (CS) requiring extracorporeal membrane oxygenation (ECMO).
We explored the role of ECMO for STEMI with profound CS.
We provided the associations of 30-day mortality post-ECMO.